Press Releases Emyria Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:20:48 28/06/2024 am IST			5-day change	1st Jan Change
0.041 ^AUD	0.00%		-6.82%	-21.15%

20/06	Emyria to Facilitate PTSD Treatment Trial	MT
11/06	Emyria CFO Steps Down	MT

Emyria opens Empax Centre to target care gaps in resistant PTSD	10/04	AQ
Emyria welcomes top healthcare leader as chairman	23/11	AQ
Emyria hails strong growth in clinical billings	27/23/27	AQ
Emyria set to begin MDMA study after securing local supply	26/23/26	AQ
Emyria provides unique combination of drug development and therapy delivery	08/23/08	AQ
Emyria advances development and commercialisation of unique drug products	02/23/02	AQ
Emyria expands mental health care capabilities with Pax Centre acquisition	04/23/04	AQ
Emyria hails ethics approval for MDMA-assisted clinical trial	08/23/08	AQ
Emyria launches new high potency Ultra-Pure CBD capsule	25/23/25	AQ
Emyria agrees licensing and commercialisation deal for EMD-RX5	05/23/05	AQ
Emyria thrilled with new collaboration for MDMA-assisted PTSD therapy	09/23/09	AQ
Emyria ramps up MDMA programs following Ã¢€˜incredibleÃ¢€™ TGA decision	08/23/08	AQ
Emyria welcomes dosing of first patient in Phase 3 anxiety trial	01/23/01	AQ
Emyria delighted to be accepted into prestigious US pain initiative	30/22/30	AQ
Emyria delighted to be accepted into prestigious US pain initiative	30/22/30	EQ
Emyria : Appendix 4C - Quarterly	28/22/28	PU
Emyria : Appendix 4C - Quarterly	27/22/27	PU
Emyria : Broker Briefing Presentation	24/22/24	PU
Emyria : Addendum to Notice of Meeting and Proxy Form	18/22/18	PU
Emyria : Hidden Gems Webinar Presentation	04/22/04	PU

No results for this search